ARTICLES BY THIS AUTHOR
- 12/30/2019
FDA approves expanded indication for Amarin’s Vascepa
Vascepa was originally approved as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. - 12/30/2019
Ortho Dermatologics gets FDA green light for Arazlo
Arazlo is the first FDA approved tazarotene acne treatment in a lotion formulation. - 12/27/2019
Lupin gets FDA OK for generic Myfortic, launches generic Hectorol
Mycophenolic acid delayed-release tablets and doxercalciferol injection had a market value of roughly $174 million and $132 million, respectively. - 12/27/2019
Amneal names 3 executives to its board of directors
Jeff George, John Kiely and Shlomo Yanai have been appointed to Amneal’s board of directors. - 12/26/2019
Merck gets FDA green light for Ervebo
Merck's Ervebo is indicated for the prevention of disease caused by Zaire ebolavirus in individuals 18 years old and older. - 12/26/2019
E5 Pharma launches generic Proglycem
e5 Pharma's diazoxide oral suspension is the first generic of Proglycem. - 12/23/2019
Lupin gets FDA OK for generic Diprolene
Betamethasone dipropionate ointment had a market value of roughly $22 million, according to IQVIA September 2019 data. - 12/23/2019
Fresenius Kabi debuts generic Bentyl
Fresenius Kabi's generic Bentyl is available in a 20 mg per 2 mL single-dose vial. - 12/20/2019
Rush, higi to extend healthcare services across Chicago
Rush and higi are collaborating to educate Chicagoans on health topics and connect them to care. - 12/19/2019
House Appropriations Committee passes CREATES Act
The CREATES Act would stop drugmakers from limiting access to brand and biologic drugs necessary for generic and biosimilar drug development.